BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37005173)

  • 1. Prognostic score for synchronous metastatic rectal cancer: A real-world study.
    Muzellec L; Campion L; Bachet JB; Taieb J; Fremont E; Senellart H; Moreau J; Bouché O; Garric M; Guimbaud R; Greilsamer C; Bodère A; Lièvre A; Girot P; Edeline J; Tougeron D; Bennouna J; Touchefeu Y
    Dig Liver Dis; 2023 Oct; 55(10):1411-1416. PubMed ID: 37005173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors of patients with unresectable liver metastasis from colorectal cancer after failed conversion chemotherapy].
    He H; Shen W; Chen W; Liu H; Gong W; Fu J; Hu X; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1261-1267. PubMed ID: 30506537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastases in locally advanced rectal cancer undergoing curatively intended treatment.
    Mariathasan AB; Boye K; Dueland S; Flatmark K; Larsen SG
    Eur J Surg Oncol; 2021 Sep; 47(9):2377-2383. PubMed ID: 34049768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients.
    Rebersek M; Mesti T; Boc M; Ocvirk J
    Radiol Oncol; 2019 Mar; 53(1):85-95. PubMed ID: 30840593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey.
    Langrand-Escure J; Diao P; Garcia MA; Wang G; Guy JB; Espenel S; Guillaume E; Rehailia-Blanchard A; Pigné G; de Laroche G; Kaczmarek D; Muron T; Porcheron J; Phelip JM; Vallard A; Magné N
    Sci Rep; 2018 Jul; 8(1):10708. PubMed ID: 30013090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and individualized nomograms predicting overall survival in stage IV rectal cancer patients with different metastatic status: a SEER-based study.
    Ge H; Zhou Z; Li Y; Wang D; Güngör C
    Transl Cancer Res; 2022 Sep; 11(9):3141-3155. PubMed ID: 36237239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
    Petersen SH; Harling H; Kirkeby LT; Wille-Jørgensen P; Mocellin S
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD004078. PubMed ID: 22419291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors.
    Yoon HI; Koom WS; Kim TH; Ahn JB; Jung M; Kim TI; Kim H; Shin SJ; Kim NK
    PLoS One; 2016; 11(8):e0161475. PubMed ID: 27536871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and prognostic factors of brain metastasis from colorectal cancer].
    Sun Z; Sun Y; Tan L; He J; Li X; She C; Li W
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):63-8. PubMed ID: 26796809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
    Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
    Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601.
    Ferrand F; Malka D; Bourredjem A; Allonier C; Bouché O; Louafi S; Boige V; Mousseau M; Raoul JL; Bedenne L; Leduc B; Deguiral P; Faron M; Pignon JP; Ducreux M
    Eur J Cancer; 2013 Jan; 49(1):90-7. PubMed ID: 22926014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
    Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study.
    Hwang EC; Hwang I; Jung SI; Kang TW; Kwon DD; Heo SH; Hwang JE; Kang SG; Kang SH; Lee JG; Kim JJ; Cheon J
    BMC Urol; 2014 May; 14():41. PubMed ID: 24885814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
    Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
    World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pelvic radiotherapy for locally advanced rectal cancer and synchronous unresectable distant metastases.
    Liu KT; Wan JF; Zhu J; Li GC; Sun WJ; Shen LJ; Cai SJ; Gu WL; Lian P; Zhang Z
    Cancer Radiother; 2016 Dec; 20(8):805-810. PubMed ID: 27777027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local treatment in the setting of de novo metastatic rectal cancer: reappraisal of prognostic factors.
    Vial N; Langrand-Escure J; Diao P; Garcia MA; Jmour O; Ben Mrad M; Guy JB; Abid W; Sotton S; Espenel S; Guillaume E; Rehailia-Blanchard A; Pigné G; Trone JC; Rancoule C; Kaczmarek D; Muron T; Le Roy B; Phelip JM; Vallard A; Magné N
    Swiss Med Wkly; 2021 Dec; 151():w30034. PubMed ID: 34964579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.